Avanafil

Chenglian Pharmaceutical is an innovative high-tech phaεrmaceutical enterprise that is market-oriented and realizes industrial development through R&D↓ innovation and technology transformation.

key word:

Pharmaceutical technology

Category:

Related

Product Description

Integrity, innovation, cooperation, sharing, win-win

The company integrates multiple resources and strives to λbuild a large health industry finance platform company integrating pharmaceutical, intelligent med ical, bio pharmaceutical R&D, industrial production  and sales.

The chemical reactions involved in the existing products include Foucault reaction, nitrat©ion reaction, sulfonation reaction, hydrogenation reaction, fluorination reaction, chlorination re'action, bromination reaction, diazotization reaction, format reaction, etc.

Related products

Sitagliptin Phosphate Monohydrate

Sitagliptin phosphate is a dipeptidyl peptidase-4 (DPP4) inhibitor develope§d by Merck. In October 2006, Sitagliptin phosphateα Januvia was approved by FDA as the first DPP4 inhi♥bitor for the treatment of type ⅱ diabetes mellitus. The₽ characteristics of this drug are that it can stimulate insulin secrαetion while reducing hunger without causing weight g×ain. Hypoglycemia and edema will not occur, and it is suitable for diabetic☆ patients with poor blood glucose control and frequent hypoglycemia.

Sumatriptan Succinate

Medication for migraine

Vildagliptin

Chenglian Pharmaceutical is an innovative high-tech pharmaceutical enterprise that iσs market-oriented and realizes industrial development through R&D innovation• and technology transformation.

Ketoprofen

The non-steroidal anti-inflammatory drug ketoprofen is one of the most important product☆s for the treatment of arthritis. It is well tolerated and has a low inc‌idence of side effects

Pranlukast

Pranlukast, developed by Ono, is one of the three major leukotriene receptor a♦ntagonists. In clinical application, it has good therapeutic effect on atopic asthma and other typ∏es of bronchial asthma, and the market prospect is huge. In the majo$r category of asthma drugs, leukotriene receptor an✔tagonists have the fastest growing market share.

Avanafil

Chenglian Pharmaceutical is an innovative high-tech pharmaceuγtical enterprise that is market-oriented and realizes industrial devel​opment through R&D innovation and technology transformation↕.

Donepezil HCL

Treatment of mild to moderate Alzheimer's syndrome. It is the¶ second drug approved by FDA for Alzheimer's disease in the Un↕ited States. Its treatment reaches the target dose and has lowλ toxic and side effects. It has been widely recognized by our medical commu€nity, and good tolerance is its biggest advantage. In October ¶1999, Donepezil was launched in China under the trade name "Aricept", which is the main chemical© drug against Alzheimer's disease. At present, CFDA has approved a number ofφ domestic enterprises to produce donepezil preparations, the main dosage forms are tab£lets, capsules, dispersive tablets, oral disintegrating "tablets.

Almotriptan

Migraine medication for adolescents

Apixaban

English name Apixaban Trade name ELIQUIS, tablet: Apixaban (Eliquis, Bristol-Myers Squibb/Pfizφer), a direct oral factor Xa inhibitor, was approved for use€ in the 27 EU member states. The world's first drug approved to prevent venous πthromboembolism (VTE) in adult patients undergoing elective hip or knee replacement. Fro→m June 2019 to June 2020, the annual sales of apixaban products overseas reached ab©out $15.4 billion, with a year-on-year growth of nearly 32%€, and the API consumption reached about 23,960 kg, w≈ith a year-on-year growth of about 28%. Compared with its main competitor, Rivaroxaban, ✔the drug's annual overseas sales are about $4.5 billion higher.

Lenvatinib

Chenglian Pharmaceutical is an innovative high-tech ph>armaceutical enterprise that is market-oriented and r✔ealizes industrial development through R&D innovation and technology transformation.

Clofarabine

It is a nucleotide analogue developed by Bioenvision and manufactured by Genzyme. On Decem₩ber 29, 2004, it was approved by FDA for the treatment of refractory or relapsed acute lymphoblasti>c leukemia (ALL) in children.

Upadacitinib(Scientific research)

Chenglian Pharmaceutical is an innovative high-tech pharmaceπutical enterprise that is market-oriented and realizes industrial development♥ through R&D innovation and technology transformation.

Product Consulting

Our staff will contact you within 24 hours (working days). If you need oth☆er services, E-mail: 2880705932@qq.com
Submit

Copyright © 2022 Anhui Union Pharmaceuticals Technology Co., Ltd.